. We analyzed various immune cells including T, B, NK, and MDSC in pleural fluid and peripheral blood.
the ROC curve of 0.92 was obtained using PMN-MDSC frequency as the indicator for TPE identification. PMN-MDSC in PPE produced high level of reactive oxygen species and suppressed the production of interferon gamma from T cells after non-specific stimulation.
Conclusion:
The levels of MDSCs in TPE were significantly lower than that in PPE. Therefore, the frequency of MDSCs in pleural fluid can be utilized to distinguish TPE from PPE. Background and Aims: Chronic obstructive pulmonary disease frequently coexists with ischemic heart disease, and is associated with poor post-operative outcomes after coronary artery bypass grafting (CABG).
Therefore, pre-operative pulmonary function tests (PFTs) are recommended. ATS/ERS PFT guidelines list myocardial infarction (MI) within one month as a contraindication, but no safety data exist regarding PFTs in other potentially unstable cardiac conditions, such as left main coronary artery disease (LMCAD). We therefore studied the safety outcomes of pre-operative PFTs in patients with LMCAD.
Methods: A retrospective review of patients who had CABG for LMCAD (≥50% angiographic narrowing) or LMCA-Equivalent Disease (LMEQD, ≥70% proximal left circumflex and proximal left coronary artery narrowing) was performed at our institution between July and December 2017. Patients who had PFTs (PFT group) were compared to those that did not (non-PFT group). Primary outcome was rate of MI or serious cardiac arrhythmia in the PFT group prior to surgery. Post-operative outcomes compared between the two groups were: days in the Intensive Care Unit (ICU), days on ventilator, pneumonia rates and total hospital length of stay. Data were analysed using paired t-test and Fisher's exact test.
Results: Forty-five patients underwent CABG for LMCAD/LMEQD; 18/45 (40%) were included in the PFT group. No patient had a MI or cardiac arrhythmia post PFTs. There was no significant difference between the PFT group and the non-PFT group for days in ICU (4.38 vs 4.0 days, P = 0.22), average time on ventilator (1.5 vs <1 days, P = 1), or pneumonia rates (16% vs 22%, P = 0.72). There was a trend towards shorter total length of stay in the PFT group (17.9 vs 24.4 days, P = 0.07).
In this small sample size of patients with LMCAD/ LMEQD, PFTs do not appear to pose a risk of precipitating MI or arrhythmia, and are safe to perform prior to major cardiac surgery for this population. made that the natural progression of COPD to chronic pulmonary hypertension, severe hypoxemia, right heart failure, and death is dependent upon the severity of nocturnal desaturation. However to detect hypoxia in patients with respiratory diseases during hospitalization by using overnight pulse oximetry and apply correct home oxygen devices is still uncommon in Taiwan. We aimed to study the clinical efficacies of nocturnal oxygen or bilevel positive airway pressure (BiPAP) in patients with intermittent nocturnal hypoxia Methods: Between June 2016-April 2018, 47 patients were screened during admission in Taiwan. Inclusion criteria were patients with COPD or other chronic lung diseases proved by series of chest images and pulmonary function tests. All of them had normal result of daytime oxygen saturation. A total 30 patient (63.8%) with intermittent nocturnal hypoxia noted at overnight pulse oximeters was included. Three patients with concomitant hypercapnia were assigned to receive nocturnal BiPAP, other 27 patients were assigned to receive nocturnal oxygen. Paired overnight pulse oximeter was performed before and after oxygen/BiPAP support.
Results: After oxygen/BiPAP supplement, basal SpO 2 increased from 90.3 to 96.5%, P < 0.001; total hypoxia (SpO 2 <88%) duration decreased from 62.2 to 6.3 min, P < 0.001; hypoxia event decreased from 75.8 to 9.5, P < 0.001. None of these 30 patients readmitted within 14 days, 9 patients readmitted within 90 days.
It is feasible to apply overnight pulse oximetry to detect nocturnal oxygen desaturation in patient with chronic lung diseases and normal daytime oxygen saturation. Nocturnal oxygen/BiPAP may improve SpO2, decrease hypoxic events and duration in patients with intermittent nocturnal hypoxia. Background and Aims: Esophagopleural fistula (EPF) is a rare condition that is caused by several benign, malignant and idiopathic diseases.
Methods:
We report an elderly patient with EPF secondary to oesophageal ulcer successfully treated with self-expandable oesophageal metallic stent.
